Ching-Tzu Hung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ching-Tzu Hung has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Chung-Hao Huang
Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
1 shared publication- Hsiao-Chen Lee
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
1 shared publication - Hsiu-Ying Lee
Hyperbaric Oxygen Therapy Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
1 shared publication - Jing-Jou Lo
Department of General Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
1 shared publication - Jong-Rung Tsai
Department of Respiratory Therapy, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
1 shared publication Jun-You Lin
Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
1 shared publication
Latest Publications
- Open Access
Proactive COVID-19 Infection Prevention Measures in a Hyperbaric Oxygen Therapy Center
Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China in December 2019 and its subsequent global spread, Taiwan has been combatting this pandemic. COVID-19 is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As SARS-CoV-2 can be transmitted through droplets and aerosols, we cannot ignore the risk of transmission during hyperbaric oxygen therapy (HBOT). Our hyperbaric oxygen therapy center prioritizes preventing the spread of COVID-19 and maintaining operation for the patients during the pandemic. The aim of this article is to share the protocol that we have adopted in our hyperbaric oxygen therapy center to help prevent the spread of COVID-19.
Open AccessProactive COVID-19 Infection Prevention Measures in a Hyperbaric Oxygen Therapy Center
Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China in December 2019 and its subsequent global spread, Taiwan has been combatting this pandemic. COVID-19 is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As SARS-CoV-2 can be transmitted through droplets and aerosols, we cannot ignore the risk of transmission during hyperbaric oxygen therapy (HBOT). Our hyperbaric oxygen therapy center prioritizes preventing the spread of COVID-19 and maintaining operation for the patients during the pandemic. The aim of this article is to share the protocol that we have adopted in our hyperbaric oxygen therapy center to help prevent the spread of COVID-19.
- Open Access
- 1 June 2018
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 51 (3) , 401-410
The epidemiology, antibiograms and predictors of mortality among critically-ill patients with central line-associated bloodstream infections
- 1 June 2018
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 51 (3) , 401-410
Open AccessThe epidemiology, antibiograms and predictors of mortality among critically-ill patients with central line-associated bloodstream infections